Medicinal Products Act.

This Act regulates the handling of medicinal products, the issuance of medical prescriptions, the granting of marketing authorizations, clinical trials, and the advertising of medicinal products. It also establishes the framework for state supervision and responsibility in the field of medicinal products to ensure their safety, quality, and efficacy within Estonia, while promoting their use for intended purposes. The scope of the requirements covers both human and veterinary medicinal products, as well as premixes of medicated feedingstuffs, ensuring they possess the presumed characteristics of use and remain safe for consumer health.
A medicinal product is defined as any substance or combination of substances intended for the prevention, diagnosis, or treatment of a disease, the relief of a disease condition, or the restoration or alteration of vital functions in a human or animal through pharmacological, immunological, or metabolic effects. Veterinary medicinal products must specifically be safe for the health of the consumer of the resulting animal product. The legislation authorizes the minister responsible for the field to establish regulations outlining the list of prohibited biostimulants, hormone preparations, and other substances for animal use, alongside special circumstances where their therapeutic use is permitted.
The text establishes the general conditions and administrative procedures for utilizing medicinal products and medicated feedingstuffs to prevent and treat animal diseases. It outlines the legal channels for dispensing veterinary and human medicinal products for animal care, requiring specific documentation such as order forms or veterinary prescriptions depending on the classification of the product. Additionally, the Act mandates clear identification and labeling requirements for all products distributed specifically for veterinary use.
The Act provides the statutory basis for the storage, transport, handling, and market withdrawal of medicinal products. It governs the authorization process for handling and brokering activities, alongside the professional registration and qualifications required for pharmacists. Finally, the framework defines the rules for marketing authorizations and sets out the mechanisms for state inspection, enforcement, and penalties in cases of non-compliance.